Cargando…

Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy

Detalles Bibliográficos
Autores principales:	Fryer, Ryan M., Boustany-Kari, Carine M., MacDonnell, Scott M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124518/ https://www.ncbi.nlm.nih.gov/pubmed/25147524 http://dx.doi.org/10.3389/fphar.2014.00185

Ejemplares similares

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
por: Orena, Stephen, et al.
Publicado: (2013)

Evaluation of the efficacy of Abelmoschus manihot (L.) on diabetic nephropathy by analyzing biomarkers in the glomeruli and proximal and distal convoluted tubules of the kidneys
por: Yu, Hongmei, et al.
Publicado: (2023)

Quercetin Attenuates Podocyte Apoptosis of Diabetic Nephropathy Through Targeting EGFR Signaling
por: Liu, Yiqi, et al.
Publicado: (2022)

Epigenetic Alterations in Podocytes in Diabetic Nephropathy
por: Sugita, Erina, et al.
Publicado: (2021)

Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis
por: Chan, Kam Wa, et al.
Publicado: (2022)

A soluble guanylate cyclase activator protects from diabetic nephropathy beyond standard of care in the ZSF1 rat
por: Pullen, Steven S, et al.
Publicado: (2015)

NLRP3-mediated pyroptosis in diabetic nephropathy
por: Wan, Jiayi, et al.
Publicado: (2022)

Cellular phenotypic transitions in diabetic nephropathy: An update
por: Cao, Yiling, et al.
Publicado: (2022)

miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression
por: Yang, Zijun, et al.
Publicado: (2018)

Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice
por: Opazo-Ríos, Lucas, et al.
Publicado: (2022)

Therapeutic effect and mechanism of combination therapy with ursolic acid and insulin on diabetic nephropathy in a type I diabetic rat model
por: Liu, Yang, et al.
Publicado: (2022)

Interactions Among Non-Coding RNAs in Diabetic Nephropathy
por: Loganathan, Tamil Selvi, et al.
Publicado: (2020)

Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy
por: Li, Wen, et al.
Publicado: (2021)

Efficacy and safety of Abelmoschus moschatus capsules combined with tripterygium glycoside tablets on diabetic nephropathy: A systematic review and meta-analysis
por: Zhou, Peipei, et al.
Publicado: (2022)

Economic evaluation of bailing capsules for patients with diabetic nephropathy in China
por: He, Yumei, et al.
Publicado: (2023)

Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats
por: Xiong, Chongxiang, et al.
Publicado: (2021)

An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
por: Huang, Xin, et al.
Publicado: (2021)

Effects of Huangqi Liuyi Decoction in the Treatment of Diabetic Nephropathy and Tissue Distribution Difference of its Six Active Constituents Between Normal and Diabetic Nephropathy Mouse Models
por: Wang, Qun, et al.
Publicado: (2022)

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice
por: Cai, Ting-Ting, et al.
Publicado: (2020)

Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy
por: Sabapathy, Vikram, et al.
Publicado: (2019)

Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
por: Zhao, Lijuan, et al.
Publicado: (2023)

Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
por: Gu, Yue-Yu, et al.
Publicado: (2021)

Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
por: Chen, Yan, et al.
Publicado: (2019)

Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy
por: Yi, Xinyao, et al.
Publicado: (2022)

Research progress on Cornus officinalis and its active compounds in the treatment of diabetic nephropathy
por: Wu, Chenguang, et al.
Publicado: (2023)

Evaluating service user & carer experience of videoconferencing software during COVID-19 pandemic
por: MacDonnell, Joseph
Publicado: (2021)

Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis
por: Han, Shisheng, et al.
Publicado: (2021)

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study
por: Luo, Mian-Na, et al.
Publicado: (2023)

Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis
por: Lin, Wenwen, et al.
Publicado: (2022)

Resveratrol Protects Against Post-Contrast Acute Kidney Injury in Rabbits With Diabetic Nephropathy
por: Wang, Yongfang, et al.
Publicado: (2019)

Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
por: Dong, Wenmin, et al.
Publicado: (2022)

The Effects of Rhubarb for the Treatment of Diabetic Nephropathy in Animals: A Systematic Review and Meta-analysis
por: Zeng, Jing-Yi, et al.
Publicado: (2021)

The role of Chinese herbal medicine in the treatment of diabetic nephropathy by regulating endoplasmic reticulum stress
por: Wei, Maoying, et al.
Publicado: (2023)

lncRNA MALAT1 Promotes Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-2355-3p/IL6ST Axis
por: Huang, Haozi, et al.
Publicado: (2021)

Reactivation of cocaine contextual memory engages mechanistic target of rapamycin/S6 kinase 1 signaling
por: Shi, Xiangdang, et al.
Publicado: (2022)

Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy
por: Shao, Yun-xia, et al.
Publicado: (2019)

The Effects of Salvianolate Combined With Western Medicine on Diabetic Nephropathy: A Systematic Review and Meta-Analysis
por: Shen, Yuehong, et al.
Publicado: (2020)

Huidouba Improved Podocyte Injury by Down-Regulating Nox4 Expression in Rats With Diabetic Nephropathy
por: Yang, KunBao, et al.
Publicado: (2020)

Dl-3-n-Butylphthalide Ameliorates Diabetic Nephropathy by Ameliorating Excessive Fibrosis and Podocyte Apoptosis
por: Xu, Jingyu, et al.
Publicado: (2021)

Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy
por: Xuan, Chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_id8cv6ibmfk1uch3skm61527rg